论文部分内容阅读
据报道,喉癌占全身癌瘤的1～2%,在头颈部癌瘤中占20～33%而居首位。多发于男性,男女之比为10:1。几年来我们随访观察了20例喉癌患者,男性16例,女性4例,男女之比为4:1。按分期组合属于Ⅰ期(T_1N_0M_0)者3例,Ⅱ期(T_2N_0M_0)者1例,Ⅲ期(T_(1-4)N_(1-2)M_0)者13例,Ⅳ期(T_(1-4)N_3M_0)者3例。4例早期患者1例行放射治疗,3例行喉部分切除,其余16例都做了全喉切除。在行全喉切除术的患者中,14例同时行患侧全颈淋巴结廓清术,2例做了双侧全颈淋巴结廓清术,术后并结合进行了化疗和放疗。观察结果,3～8年仍健在者10例。1.5年
According to reports, laryngeal cancer accounts for 1 to 2% of all body cancers, and it accounts for 20 to 33% of head and neck cancers. More often than men, the male to female ratio is 10:1. In the past few years, we have followed up 20 patients with laryngeal cancer, including 16 males and 4 females. The ratio between males and females is 4:1. According to the staging, there were 3 cases of stage I (T_1N_0M_0), 1 case of stage II (T_2N_0M_0), 13 cases of stage III (T_(1-4)N_(1-2)M_0), and stage IV (T_(1-). 4) N_3M_0) in 3 cases. Radiotherapy was performed in 1 of the 4 early patients, partial laryngectomy was performed in 3 patients, and total laryngectomy was performed in the other 16 patients. Of the patients who underwent total laryngectomy, 14 patients underwent bilateral lymph node dissection at the same time, and 2 patients underwent bilateral neck dissection. Postoperative chemotherapy and radiotherapy were combined. Observing the results, 10 cases were still alive in 3-8 years. 1.5 years